319
Views
16
CrossRef citations to date
0
Altmetric
Pharmacological Aspects

Sex-dependent modulation of treatment response

La modulación de la respuesta al tratamiento ndíente del sexo

Modulation sexe-dépendante de la réponse au traitement

&
Pages 39-51 | Published online: 01 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bridget Myers, Vidhatha Reddy, Stephanie Chan, Quinn Thibodeaux, Nicholas Brownstone & John Koo. (2022) Optimizing doxepin therapy in dermatology: introducing blood level monitoring and genotype testing. Journal of Dermatological Treatment 33:1, pages 87-93.
Read now
Jean-Paul Macher & Marc-Antoine Crocq. (2004) Treatment goals: response and nonresponse. Dialogues in Clinical Neuroscience 6:1, pages 83-91.
Read now

Articles from other publishers (14)

Lara Marques & Nuno Vale. (2023) Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine. Pharmaceutics 15:6, pages 1586.
Crossref
Colleen Carmody, Charlotte G Duesing, Alice E Kane & Sarah J Mitchell. (2022) Is Sex as a Biological Variable Still Being Ignored in Preclinical Aging Research?. The Journals of Gerontology: Series A 77:11, pages 2177-2180.
Crossref
Rossana Roncato, Jacopo Angelini, Arianna Pani, Erika Cecchin, Andrea Sartore-Bianchi, Salvatore Siena, Elena De Mattia, Francesco Scaglione & Giuseppe Toffoli. (2020) CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions. International Journal of Molecular Sciences 21:17, pages 6350.
Crossref
Jose Vicente, Nan Zheng, Girish Bende & Christine Garnett. 2020. Sex and Cardiac Electrophysiology. Sex and Cardiac Electrophysiology 799 806 .
David R. Rubinow & Peter J. Schmidt. (2018) Sex differences and the neurobiology of affective disorders. Neuropsychopharmacology 44:1, pages 111-128.
Crossref
D. P. Romodanovsky, D. V. Goryachev, A. L. KhokhlovA. E. Miroshnikov. (2018) INFLUENCE OF SEX DIFFERENCES ON PHARMACOKINETICS OF DRUGS WITHIN THE FRAMEWORK OF BIOEQUIVALENCE STUDIES OF GENERIC MEDICINAL PRODUCTS. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 3:5, pages 94-105.
Crossref
JOSÉ WELLITHOM VITURINO DA SILVA, RAFAEL FERREIRA DE LIMA, ANA ROSA BRISSANT DE ANDRADE, JULIANA KISHISHITA, LEILA BASTOS LEAL & GIOVANA DAMASCENO SOUSA. (2017) INFLUÊNCIA DO GÊNERO EM ESTUDOS DE BIOEQUIVALÊNCIA DE MEDICAMENTOS. Infarma - Ciências Farmacêuticas 29:1, pages 61-67.
Crossref
Nobuharu Fujiwara, Atsushi Tanaka, Atsushi Kawaguchi, Motoko Tago, Jun-ichi Oyama, Yasufumi Uchida, Kazuo Matsunaga, Kazuo Moroe, Shigeru Toyoda, Teruo Inoue, Hideo Ikeda & Koichi Node. (2017) Association Between Blood Pressure Lowering and Quality of Life by Treatment of Azilsartan. International Heart Journal 58:5, pages 752-761.
Crossref
Mónica Flores-Ramos, Philippe Leff, Alonso Fernández-Guasti & Claudia Becerra Palars. (2017) Is it important to consider the sex of the patient when using lithium or valproate to treat the bipolar disorder?. Pharmacology Biochemistry and Behavior 152, pages 105-111.
Crossref
Belinda Huerta, Luigi Margiotta‐Casaluci, Sara Rodríguez‐Mozaz, Martin Scholze, Matthew J. Winter, Damià Barceló & John P. Sumpter. (2016) Anti‐anxiety drugs and fish behavior: Establishing the link between internal concentrations of oxazepam and behavioral effects. Environmental Toxicology and Chemistry 35:11, pages 2782-2790.
Crossref
Luiz Fernando de Almeida Lima e Silva, Júlia Cunha Loureiro, Stephany Caroline Raposo Franco, Marilza de Lima Santos, Rodrigo Secolin, Iscia Lopes-Cendes, Clarissa de Rosalmeida Dantas & Claudio E. M. Banzato. (2016) Assessing treatment response to prophylactic lithium use in patients with bipolar disorder. Jornal Brasileiro de Psiquiatria 65:1, pages 9-16.
Crossref
Alina Karanti, Christian Bobeck, Maja Osterman, Mathias Kardell, Dag Tidemalm, Bo Runeson, Paul Lichtenstein & Mikael Landén. (2015) Gender differences in the treatment of patients with bipolar disorder: A study of 7354 patients. Journal of Affective Disorders 174, pages 303-309.
Crossref
Mary V. Seeman. (2012) Treating schizophrenia at the time of menopause. Maturitas 72:2, pages 117-120.
Crossref
G. S. Malhi, M. Berk, M. Bourin, B. Ivanovski, S. Dodd, J. Lagopoulos & P. B. Mitchell. (2008) Atypical mood stabilizers: a ‘typical’ role for atypical antipsychotics. Acta Psychiatrica Scandinavica 111:s426, pages 29-38.
Crossref